View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Ophthalmic Business News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 06, 2024
4 min read
Save

PBMs vs. patients: The hidden battle for affordable biosimilars

PBMs vs. patients: The hidden battle for affordable biosimilars

Biosimilar medications — drugs developed to be very similar, but not identical, to an FDA-approved biologic — were intended to play a vital role in increasing affordable options for patients struggling with a range of chronic conditions.

SPONSORED CONTENT
September 05, 2024
50 min listen
Save

Innovations in eye care with Steven Schwartz, MD, and Sean Ianchulev, MD (Re-Release)

Innovations in eye care with Steven Schwartz, MD, and Sean Ianchulev, MD (Re-Release)

In this special throwback episode, John Hovanesian, MD, and Jim Mazzo revisit their discussions with Steven Schwartz, MD, and Sean Ianculev, MD, about innovations, treatments and entrepreneurship in eye care.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
September 04, 2024
1 min read
Save

FDA clears investigational new drug application for photoreceptor disease therapy

FDA clears investigational new drug application for photoreceptor disease therapy

The FDA cleared an investigational new drug application for OpCT-001, an investigational cell therapy for the treatment of primary photoreceptor diseases, according to a press release from BlueRock Therapeutics.

SPONSORED CONTENT
September 03, 2024
5 min read
Save

Qualified retirement plans offer pros and cons for practice owners and employees

Qualified retirement plans offer pros and cons for practice owners and employees

Retirement planning for physicians is a critical aspect of financial management, given the unique challenges and opportunities they face.

SPONSORED CONTENT
August 30, 2024
1 min watch
Save

VIDEO: Elios Vision to launch excimer laser for glaucoma in 2025

VIDEO: Elios Vision to launch excimer laser for glaucoma in 2025

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Cari Stone of Elios Vision previews the company’s excimer laser for the treatment of glaucoma.

SPONSORED CONTENT
August 28, 2024
2 min watch
Save

VIDEO: Save early, understand retirement account taxes when building wealth

VIDEO: Save early, understand retirement account taxes when building wealth

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Carole C. Foos, CPA, of OJM Group discusses saving and investing pearls for ophthalmologists.

SPONSORED CONTENT
August 28, 2024
1 min read
Save

European Commission grants marketing authorization to Akantior for Acanthamoeba keratitis

European Commission grants marketing authorization to Akantior for<i> </i><i>A</i><i>canthamoeba</i> keratitis

The European Commission granted marketing authorization to Akantior for the treatment of Acanthamoeba keratitis, according to a press release from Avanzanite Bioscience.

SPONSORED CONTENT
August 26, 2024
1 min read
Save

Dollar cost averaging and lump sum investing: Time in the market is key

Dollar cost averaging and lump sum investing: Time in the market is key

Most physicians receive a regular paycheck, and sometimes receive a lump sum such as a bonus. A proportion of both should be invested. How should one invest a portion of their regular paycheck?

SPONSORED CONTENT
August 22, 2024
1 min read
Save

Icare Finland Oy acquires Thirona Retina

Icare Finland Oy acquires Thirona Retina

Icare Finland Oy, a subsidiary of Revenio Group, has signed an agreement to acquire the AI software company Thirona Retina, according to a press release.

SPONSORED CONTENT
August 21, 2024
1 min read
Save

FDA grants rare pediatric disease designation for Leber congenital amaurosis gene therapy

FDA grants rare pediatric disease designation for Leber congenital amaurosis gene therapy

Opus Genetics received rare pediatric disease designation from the FDA for its ocular gene therapy designed to treat patients with a form of Leber congenital amaurosis, according to a press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails